Kiwa Bio-tech Products Group Corp (KWBT) financial statements (2020 and earlier)

Company profile

Business Address 3200 GUASTI ROAD,
ONTARIO, CA 91761
State of Incorp. NV
Fiscal Year End December 31
SIC 287 - Agricultural Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,021103578115,08262
Cash and cash equivalents2,021103578115,08262
Receivables3,5143,5417,1426,7636,7777,01724
Inventory, net of allowances, customer advances and progress billings1411151171,6431,6451,70613,624
Inventory1411151171,6431,6451,70613,624
Prepaid expense1,4341,8401,9092,2602,8583,1183,668
Deferred costs2,4272,5185,0514,9304,9245,10913
Other undisclosed current assets22,78223,37420,45816,08713,6936,5536,853
Total current assets:32,32031,39835,03431,69029,90928,58524,244
Noncurrent Assets
Operating lease, right-of-use asset54  
Property, plant and equipment701189093556475
Long-term investments and receivables702728745727728755797
Long-term investments702728745727728755797
Deposits noncurrent assets   117488
Total noncurrent assets:825846835821784893960
TOTAL ASSETS:33,14532,24435,86932,51130,69329,47825,204
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,19910,1408,8047,6046,3035,1917,409
Accounts payable2,2612,5512,0811,6111,2298803,473
Employee-related liabilities1,3911,2601,1261,025738487373
Taxes payable4,2774,1713,5462,9472,4021,9681,722
Interest and dividends payable2,2702,1582,0512,0211,9351,8561,840
Deferred revenue3,2523,3736,917
Debt159138138360360360360
Derivative instruments and hedges, liabilities206917346118
Due to related parties275291261571553528420
Deferred revenue and credits24
Contract with customer, liability6,751   
Other liabilities2,8032,8402,8242,9402,8222,8462,448
Other undisclosed current liabilities2,8182,2891,6761,5528,1457,850879
Total current liabilities:19,52519,14120,62119,78518,18816,82011,658
Noncurrent Liabilities
Long-term debt and lease obligation33    587562
Long-term debt, excluding current maturities     587562
Operating lease, liability33  
Total noncurrent liabilities:33    587562
Total liabilities:19,55819,14120,62119,78518,18817,40812,220
Stockholders' equity
Stockholders' equity attributable to parent, including:13,58713,10315,24812,72712,50512,07112,984
Preferred stock11     
Common stock20191917171716
Common stock, share subscribed but unissued, subscriptions receivable(1,023)(1,023)(1,023)(1,023)(458)(458)458
Additional paid in capital30,11929,28328,76427,04727,09826,71826,214
Accumulated other comprehensive income (loss)(1,229)(565)(146)(558)(527)42823
Accumulated deficit(16,347)(16,659)(14,413)(14,804)(14,542)(15,165)(14,529)
Other undisclosed stockholders' equity attributable to parent2,0452,0452,0472,0479189181
Total stockholders' equity:13,58713,10315,24812,72712,50512,07112,984
TOTAL LIABILITIES AND EQUITY:33,14532,24435,86932,51130,69329,47825,204

Income statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues10,98610,9259,5438,8397,7265,3358,755
Cost of revenue
(Cost of Goods and Services Sold)
(8,409)(7,753)(7,367)(6,760)(5,452)(3,874)(6,309)
Gross profit:2,5773,1722,1762,0792,2731,4612,446
Operating expenses(725)(3,915)(997)(1,104)(1,062)(1,715)(1,789)
Operating income (loss):1,853(743)1,1799751,211(253)657
Nonoperating expense(1,290)(789)(267)(178)(73)(24)(64)
Foreign currency transaction gain (loss), before tax3522(23)13656(38)
Other nonoperating income (expense)(1)(3)55    
Interest and debt expense(1,372)(836)(30)(175)(152)(153)(155)
Other undisclosed income from continuing operations before equity method investments, income taxes1,37283630175152153155
Income (loss) from continuing operations before income taxes:563(1,532)9127971,138(277)593
Income tax expense (benefit)252(714)521495514358539
Other undisclosed loss from continuing operations   (989)(1,029)(716)(1,079)
Net income (loss):815(2,246)1,432303623(635)54
Other undisclosed net loss attributable to parent(504) (1,042)    
Net income (loss) available to common stockholders, diluted:311(2,246)391303623(635)54

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income (loss):815(2,246)1,432303623(635)54
Other comprehensive income (loss)(664)(419)412    
Other undisclosed comprehensive loss   (882)   
Comprehensive income (loss):151(2,664)1,845(579)623(635)54
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(504) (1,042)851(570)(781)499
Comprehensive income (loss), net of tax, attributable to parent:(353)(2,664)80327254(1,416)553

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: